2017 ASH MHM: Focus on Myeloma – S. Vincent Rajkumar, MD
1,682 views · Published 24 March 2017 · 1:57 · Indexed 12 November 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
S. Vincent Rajkumar, MD, discusses exciting advances in myeloma, including new drugs in the pipeline (e.g., selinexor and venetoclax). Myeloma is one of the core malignancies covered at the ASH Meeting on Hematologic Malignancies (MHM), a practical and practice-focused meeting that offers an ideal learning experience for physicians who treat hematologic malignancies. The meeting’s expert speakers discuss challenging patient cases, present new data, and provide insight into how physicians can apply new treatments to patients the very next day. Learn more about the ASH Meeting on Hematologic Malignancies at http://www.hematology.org/Malignancies/
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding